Seeking Alpha

NRX
  NephroGenex - NASDAQ

11/23/2014, 9:47 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
NRX vs. ETF Alternatives
Company Description
NephroGenex Inc is a drug development company. The Company is engaged in developing novel therapies for kidney disease. It has commercial rights to Pyridorin and conducted a Phase 2b clinical study in diabetic nephropathy patients.
Sector: Healthcare
Industry: Biotechnology
Country: United States